Consensus recommendations for the use of automated insulin delivery technologies in clinical practice
M Phillip, R Nimri, RM Bergenstal… - Endocrine …, 2023 - academic.oup.com
The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …
2022 National standards for diabetes self-management education and support
J Davis, AH Fischl, J Beck, L Browning… - The science of …, 2022 - journals.sagepub.com
Purpose: The National Standards for Diabetes Self-Management Education and Support
(DSMES) provide guidance and evidence-based, quality practice for all DSMES services …
(DSMES) provide guidance and evidence-based, quality practice for all DSMES services …
Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative
Health care inequities among racial and ethnic groups remain prevalent. For people with
type 1 diabetes who require increased medical access and care, disparities are seen in …
type 1 diabetes who require increased medical access and care, disparities are seen in …
Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes
OBJECTIVE Disparities in type 1 diabetes related to use of technologies like continuous
glucose monitors (CGMs) and utilization of diabetes care are pronounced based on …
glucose monitors (CGMs) and utilization of diabetes care are pronounced based on …
Interventions to address global inequity in diabetes: international progress
AF Walker, S Graham, L Maple-Brown, LE Egede… - The Lancet, 2023 - thelancet.com
Diabetes is a serious chronic disease with high associated burden and disproportionate
costs to communities based on socioeconomic, gender, racial, and ethnic status. Addressing …
costs to communities based on socioeconomic, gender, racial, and ethnic status. Addressing …
The role of structural racism and geographical inequity in diabetes outcomes
Diabetes is pervasive, exponentially growing in prevalence, and outpacing most diseases
globally. In this Series paper, we use new theoretical frameworks and a narrative review of …
globally. In this Series paper, we use new theoretical frameworks and a narrative review of …
Disparities in hemoglobin A1c levels in the first year after diagnosis among youths with type 1 diabetes offered continuous glucose monitoring
A Addala, V Ding, DP Zaharieva, FK Bishop… - JAMA Network …, 2023 - jamanetwork.com
Importance Continuous glucose monitoring (CGM) is associated with improvements in
hemoglobin A 1c (HbA 1c) in youths with type 1 diabetes (T1D); however, youths from …
hemoglobin A 1c (HbA 1c) in youths with type 1 diabetes (T1D); however, youths from …
The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence
MJ Redondo, I Libman, DM Maahs, SK Lyons… - Diabetes …, 2021 - Am Diabetes Assoc
The American Diabetes Association 2020 Standards of Medical Care in Diabetes
(Standards of Care) recommends a hemoglobin A1c (A1C) of< 7%(53 mmol/mol) for many …
(Standards of Care) recommends a hemoglobin A1c (A1C) of< 7%(53 mmol/mol) for many …
Eradicating racism: an endocrine society policy perspective
R Dhaliwal, RI Pereira, AM Diaz-Thomas… - The Journal of …, 2022 - academic.oup.com
Abstract The Endocrine Society recognizes racism as a root cause of the health disparities
that affect racial/ethnic minority communities in the United States and throughout the world …
that affect racial/ethnic minority communities in the United States and throughout the world …
Racial disparities in access and use of diabetes technology among adult patients with type 1 diabetes in a US academic medical center
OBJECTIVE Recent studies highlight racial disparities in insulin pump (PUMP) and
continuous glucose monitor (CGM) use in children and adolescents with type 1 diabetes …
continuous glucose monitor (CGM) use in children and adolescents with type 1 diabetes …